Latest Prosight Management, LP Stock Portfolio
$334Million– No. of Holdings #46
Prosight Management, LP Performance:
2024 Q2: -14.03%YTD: -14.03%2023: -2.77%
Performance for 2024 Q2 is -14.03%, and YTD is -14.03%, and 2023 is -2.77%.
About Prosight Management, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Prosight Management, LP reported an equity portfolio of $334.6 Millions as of 30 Jun, 2024.
The top stock holdings of Prosight Management, LP are , ADCT, ROIV. The fund has invested 10% of it's portfolio in GALAPAGOS NV and 9% of portfolio in ADC THERAPEUTICS SA.
The fund managers got completely rid off GUARDANT HEALTH INC (GH), PFIZER INC (PFE) and MARAVAI LIFESCIENCES HLDGS I (MRVI) stocks. They significantly reduced their stock positions in KEZAR LIFE SCIENCES INC (KZR), MEDTRONIC PLC (MDT) and BIOCRYST PHARMACEUTICALS INC (BCRX). Prosight Management, LP opened new stock positions in SYNDAX PHARMACEUTICALS INC (SNDX), SCHRODINGER INC (SDGR) and ACCOLADE INC (ACCD). The fund showed a lot of confidence in some stocks as they added substantially to ZIMMER BIOMET HOLDINGS INC (ZBH), VIKING THERAPEUTICS INC (VKTX) and ZYMEWORKS INC (ZYME).
The top stock holdings of Prosight Management, LP are , ADCT, ROIV. The fund has invested 10% of it's portfolio in GALAPAGOS NV and 9% of portfolio in ADC THERAPEUTICS SA.
The fund managers got completely rid off GUARDANT HEALTH INC (GH), PFIZER INC (PFE) and MARAVAI LIFESCIENCES HLDGS I (MRVI) stocks. They significantly reduced their stock positions in KEZAR LIFE SCIENCES INC (KZR), MEDTRONIC PLC (MDT) and BIOCRYST PHARMACEUTICALS INC (BCRX). Prosight Management, LP opened new stock positions in SYNDAX PHARMACEUTICALS INC (SNDX), SCHRODINGER INC (SDGR) and ACCOLADE INC (ACCD). The fund showed a lot of confidence in some stocks as they added substantially to ZIMMER BIOMET HOLDINGS INC (ZBH), VIKING THERAPEUTICS INC (VKTX) and ZYMEWORKS INC (ZYME).
Prosight Management, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Prosight Management, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Prosight Management, LP made a return of -14.03% in the last quarter. In trailing 12 months, it's portfolio return was -9.69%.
New Buys
| Ticker | $ Bought |
|---|---|
| syndax pharmaceuticals inc | 11,323,200 |
| schrodinger inc | 7,141,510 |
| accolade inc | 5,332,500 |
| cvs health corp | 2,362,400 |
| vincerx pharma inc | 2,015,620 |
| inspire med sys inc | 1,873,620 |
| paragon 28 inc | 1,787,980 |
| addus homecare corp | 1,451,380 |
New stocks bought by Prosight Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| zimmer biomet holdings inc | 799 |
| viking therapeutics inc | 194 |
| zymeworks inc | 187 |
| dexcom inc | 114 |
| privia health group inc | 113 |
| option care health inc | 105 |
| prothena corp plc | 68.32 |
| immunovant inc | 66.67 |
Additions to existing portfolio by Prosight Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| kezar life sciences inc | -94.18 |
| medtronic plc | -83.33 |
| biocryst pharmaceuticals inc | -71.52 |
| universal hlth svcs inc | -68.76 |
| orthopediatrics corp | -52.13 |
| kura oncology inc | -34.39 |
| mirum pharmaceuticals inc | -32.3 |
| erasca inc | -24.86 |
Prosight Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| maravai lifesciences hldgs i | -5,197,320 |
| guardant health inc | -9,696,100 |
| nuvation bio inc | -910,000 |
| pfizer inc | -5,966,250 |
| corbus pharmaceuticals hldgs | -3,948,210 |
| pacira biosciences inc | -2,757,260 |
| avrobio inc | -725,144 |
| absci corporation | -142,000 |
Prosight Management, LP got rid off the above stocks
Sector Distribution
Prosight Management, LP has about 82.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 82.8 |
| Others | 17.2 |
Market Cap. Distribution
Prosight Management, LP has about 10.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 29.6 |
| UNALLOCATED | 26.3 |
| MID-CAP | 25.5 |
| LARGE-CAP | 10.2 |
| MICRO-CAP | 7.4 |
Stocks belong to which Index?
About 63.1% of the stocks held by Prosight Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54 |
| Others | 36.9 |
| S&P 500 | 9.1 |
Prosight Management, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Prosight Management, LP
Prosight Management, LP has 46 stocks in it's portfolio. About 58.8% of the portfolio is in top 10 stocks. STTK proved to be the most loss making stock for the portfolio. MIRM was the most profitable stock for Prosight Management, LP last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 2.08 | 2,352,630 | 6,963,790 | added | 31.43 | ||
| ABSI | absci corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACCD | accolade inc | 1.59 | 1,489,520 | 5,332,500 | new | |||
| ADCT | adc therapeutics sa | 9.04 | 9,570,000 | 30,241,200 | added | 35.74 | ||
| ADUS | addus homecare corp | 0.43 | 12,500 | 1,451,380 | new | |||
| AGIO | agios pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALKS | alkermes plc | 1.98 | 275,000 | 6,627,500 | added | 27.91 | ||
| ALRN | aileron therapeutics inc | 0.22 | 265,000 | 734,050 | new | |||
| AVRO | avrobio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 6.06 | 800,000 | 20,264,000 | added | 35.7 | ||
| BBSI | barrett business svcs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCRX | biocryst pharmaceuticals inc | 0.74 | 398,700 | 2,463,970 | reduced | -71.52 | ||
| BMEA | biomea fusion inc | 0.17 | 124,377 | 559,697 | added | 65.84 | ||
| COGT | cogent biosciences inc | 1.26 | 500,000 | 4,215,000 | reduced | -9.99 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CVS | cvs health corp | 0.71 | 40,000 | 2,362,400 | new | |||
| CYTK | cytokinetics inc | 3.72 | 230,000 | 12,461,400 | reduced | -6.12 | ||
| DXCM | dexcom inc | 1.67 | 49,317 | 5,591,560 | added | 114 | ||
| ERAS | erasca inc | 1.94 | 2,750,000 | 6,490,000 | reduced | -24.86 | ||
| FNA | paragon 28 inc | 0.53 | 261,400 | 1,787,980 | new | |||